ISRCTN ISRCTN79558333
DOI https://doi.org/10.1186/ISRCTN79558333
Secondary identifying numbers N0203125673
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
26/07/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mark Daly
Scientific

Royal Devon & Exeter Hospital (Wonford)
Barrack Road
Exeter
EX2 5DW
United Kingdom

Phone +44 (0)1392 403086
Email M.E.Daly@exeter.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleImproving insulin treatment
Study objectivesIs post-prandial targeting of glucose better than pre-prandial targeting when using insulin glargine and novorapid in combination?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNutritional, Metabolic, Endocrine: Diabetes
InterventionRandomised Controlled Trial
1. Glargine/novorapid/fasting and post-prandial titration of insulin doses
2. Glargine/novorapid/fasting and pre-prandial titration of insulin doses
30 patients with Type I diabetes will be recruited via clinicians (medical and nursing staff) within the Exeter Diabetes Centre, fully informed and having given written consent. Prior to randomisation, each patient will wear a continuous glucose monitor for 72 hours and have blood samples taken for HbAlc. Each patient will then be randomised to receive one of two treatments. One group will be transferred to the intervention (glargine/novorapid/fasting and post-prandial titration of insulin doses) and followed up for three months. The second group will be randomised to the same insulin regimen but insulin doses will be titrated against pre-prandial and fasting measurements. Both groups will undergo a similar protocol of specialist nurse contact and intensification of their glycaemic control. 72 hours of continuous glucose monitoring system (CGMS) will take place before treatment and at the end of the three month period. Food and exercise diaries will be kept for these periods and patients will be asked to replicate the initial pattern of food and exercise for the second period.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Insulin
Primary outcome measureTo see if adjusting pre-prandial insulin on the basis of post-prandial measurements is feasible as a clinical approach in the routine clinical situation and to explore the possibility that it might improve overall diabetes control.
Secondary outcome measuresNot provided at time of registration
Overall study start date22/04/2003
Completion date22/11/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participants30
Key inclusion criteria1. Type 1 diabetes
2. >2 years duration
3. Clinical decision for glargine/novorapid therapy independently of the study
4. Fully informed and consented
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment22/04/2003
Date of final enrolment22/11/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Devon & Exeter Hospital (Wonford)
Exeter
EX2 5DW
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Royal Devon and Exeter NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

26/07/2016: No publications found, verifying study status with principal investigator.